Amanita muscaria is a wild mushroom famous for its bright red cap dotted with white spots. It grows across temperate and boreal forests in the northern hemisphere, forms symbiotic relationships with trees, and contains psychoactive compounds that act on the brain’s inhibitory signaling system. Despite its fairy-tale appearance and centuries of human use, it is toxic and can cause serious harm when ingested.
How to Identify It
The cap ranges from 4 to 21 cm in diameter, though specimens as wide as 50 cm have been recorded. It starts out convex and flattens with age. The classic variety is bright red, covered in raised white warts that are remnants of a tissue layer (called the universal veil) that once enclosed the entire mushroom. Underneath the cap, the gills are white and free from the stem. The stem itself is white with a ring near the top and concentric rings at its swollen base.
Not every fly agaric is red. The variety known as guessowii has a yellow cap. Flavivolvata and inzengae are orange with yellowish warts. There is even an entirely white variety called alba. These color differences can make identification tricky in the field, especially for foragers unfamiliar with the species’ range of appearances.
Where It Grows
Amanita muscaria is an ectomycorrhizal fungus, meaning it attaches to tree roots and exchanges nutrients with its host. It partners with birch, oak, chestnut, pine, spruce, and fir trees, thriving in the acidic, nutrient-poor soils typical of deciduous and coniferous forests. Its native range spans North America, Europe, and northern Asia.
It has also spread to the southern hemisphere. Non-native tree plantations in Chile, South Africa, New Zealand, and Australia accidentally introduced the fungus along with imported saplings. In Colombia, trees planted to combat deforestation carried the mushroom with them, and it has since formed new partnerships with native tree species.
What Makes It Psychoactive
Two compounds do the heavy lifting: ibotenic acid and muscimol. A fresh, average-sized cap can contain up to 70 mg of ibotenic acid. When the mushroom dries or is heated, ibotenic acid loses a chemical group and converts into muscimol, which is the more potent psychoactive substance.
Muscimol works by mimicking GABA, the brain’s primary calming chemical messenger. It binds to a specific subset of GABA receptors that sit outside the main signaling junctions between nerve cells. These receptors normally provide a steady, low-level brake on neural activity. When muscimol activates them, it amplifies that braking effect, producing sedation, altered perception, and changes in motor coordination. Ibotenic acid, by contrast, can stimulate certain brain pathways, which is why ingestion sometimes produces a confusing mix of sedation and agitation at the same time.
What Happens After Ingestion
Symptoms typically begin 30 minutes to 2 hours after eating the mushroom. The earliest signs are often gastrointestinal: nausea, vomiting, and abdominal discomfort. Neurological effects follow quickly, including dizziness, confusion, visual and auditory hallucinations, and impaired coordination. Dry mouth and dilated pupils are common. Many people become drowsy and eventually fall into a deep sleep with vivid dreams, usually around two hours after onset.
Most cases resolve within 5 to 24 hours without lasting damage. In more severe poisonings, the picture is different. The FDA has documented cases involving seizures, dangerously high blood pressure, rapid heart rate, respiratory depression, coma, and death. A 2022 review of poison control data from Oregon and Alaska identified 23 cases of Amanita muscaria exposure, with symptoms falling into three categories: gastrointestinal effects, central nervous system depression from muscimol, and central nervous system excitation from ibotenic acid. Some patients required hospitalization, intubation, and critical care.
There is no established lethal dose for humans. In mice, the lethal dose of muscimol is 8.1 mg per kilogram of body weight. Human sensitivity varies widely depending on the mushroom’s potency, the person’s size, and how the mushroom was prepared. The psychoactive threshold for ibotenic acid sits between roughly 30 and 90 mg, while muscimol becomes active at doses as low as 6 to 10 mg.
Historical Use in Siberia
Indigenous peoples across Siberia and northeast Asia have a long tradition of consuming Amanita muscaria for its psychoactive properties. Ethnographic research documents its use as a psychostimulant that affects multiple mental functions simultaneously. Communities that used it were aware of its variable effects and developed specific rules around dosing and administration. The mushroom played roles in shamanic practice, communal gatherings, and endurance tasks, with preparation methods varying between cultures to manage its unpredictable potency.
Legal Status
Amanita muscaria, muscimol, and ibotenic acid are not scheduled under the U.S. Controlled Substances Act or under comparable international drug laws in most countries. In the United States, you can legally possess, pick, and grow it in every state except Louisiana, which lists it among prohibited hallucinogenic substances. Outside the U.S., sales are restricted in a handful of jurisdictions including Australia, the Netherlands, Sweden, Romania, Russia, Ukraine, Thailand, and Brazil.
This legal gray area has fueled a growing commercial market. Products labeled as “mushroom edibles,” “psychedelic gummies,” or “legal psychedelics” containing Amanita muscaria extracts have become widely available online and in retail shops. That market prompted regulatory action in late 2024.
The 2024 FDA Warning
On December 18, 2024, the FDA issued a formal letter to food manufacturers stating that Amanita muscaria, its extracts, and its key constituents (muscimol, ibotenic acid, and muscarine) are not authorized for use as ingredients in conventional food. The agency concluded that these substances do not meet the safety standard known as “Generally Recognized As Safe” and that their use in food products may be harmful.
The FDA’s decision was driven by adverse event reports, news coverage of hospitalizations, and inquiries from state and local regulators asking about the legal and safety status of these products. The agency’s “Bad Bug Book,” a reference guide for foodborne hazards, has listed Amanita muscaria as a toxic agent since 2012. The new guidance goes further by explicitly recommending that consumers avoid eating any food containing the mushroom or its constituents.
The core problem is dosing consistency. The amount of ibotenic acid and muscimol in any given mushroom varies enormously depending on its size, maturity, variety, and growing conditions. Commercial products rarely standardize these concentrations reliably, making it difficult for a consumer to predict what effect a given gummy or extract will have. The gap between a psychoactive dose and a dose that causes seizures or respiratory failure is not large, and without precise quality control, that gap becomes a gamble.